JEREMY B. HAYDEN
CIK 1650737 · Chief Legal Officer · last filed 2026-04-09
JEREMY B. HAYDEN is a Chief Legal Officer who has filed 34 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing shows the insider sold $48.9K of SGHT on Apr 9, 2026. Across all open-market trades the lifetime net is −$798.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.90M
3
34
-$798.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SGHT | Chief Legal Officer | 369,770 | $5.13 | $1.90M | -$808.3K | 22 | 2026-04-09 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | General Counsel | 32,040 | — | — | $0 | 5 | 2019-10-07 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | General Counsel & VP of BD | 3,643 | — | — | $10.0K | 7 | 2017-03-17 |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-09 | SGHT | Sell (S) | −13,761 | -$48.9K | EDGAR |
| 2026-02-05 | SGHT | Grant (A) | +115,920 | $0 | EDGAR |
| 2026-01-21 | SGHT | Sell (S) | −6,308 | -$41.8K | EDGAR |
| 2026-01-06 | SGHT | Sell (S) | −11,170 | -$86.7K | EDGAR |
| 2025-11-26 | SGHT | Mixed | — | -$274.5K | EDGAR |
| 2025-11-14 | SGHT | Mixed | — | -$19.1K | EDGAR |
| 2025-10-03 | SGHT | Sell (S) | −9,731 | -$31.8K | EDGAR |
| 2025-07-07 | SGHT | Sell (S) | −9,160 | -$38.2K | EDGAR |
| 2025-04-03 | SGHT | Sell (S) | −9,395 | -$21.7K | EDGAR |
| 2025-03-13 | SGHT | Grant (A) | +139,785 | $0 | EDGAR |